BioPorto A/S: financial analysis
Ratios worked out from 3 fiscal years of BioPorto A/S's statements, compared with 88 companies in Diagnostics and Research.
Financial strength#
| Fiscal year | Trend | 2025 | 2024 | 2023 | Median of peers | Ahead of |
|---|---|---|---|---|---|---|
| Equity share of assets | 75.4% | — | — | 51.6% | 78% |
How each figure is worked out#
- Equity share of assets
- Shareholders' equity as a share of total assets.